Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FHF00
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,158
Award facts
- Contract value 100% obligated
- $14,158.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $14,158.17. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of June 2, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical IDC enables AmerisourceBergen to supply pharmaceutical products to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with plans underway for potential future multi-award regional contracts under the Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DB25FHF00?
SPE2DB25FHF00 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FHF00 worth?
The government has obligated $14,158 on SPE2DB25FHF00.
Is contract SPE2DB25FHF00 an order under another contract?
Yes. SPE2DB25FHF00 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHF00 competed?
The extent of competition for SPE2DB25FHF00 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award